Introducing Vaxdigm
Introducing Vaxdigm
A bio firm targeting both the vaccine and growth factor markets
using a microbe-based recombinant protein production platform
which reduces production costs beyond 50%
Our Company
We design advanced biomaterials like FGF to the highest precision
Re-writing the Standards of Biology
We present the new standard for next-generation biomaterials,
as we innovate the production paradigm for bio firms globally.
A bio firm targeting both the vaccine and growth factor markets
using a microbe-based recombinant protein production platform
which reduces production costs beyond 50%
Our Company
We design advanced biomaterials like FGF to the highest precision
Re-writing the Standards of Biology
We present the new standard for next-generation biomaterials,
as we innovate the production paradigm for bio firms globally.
Vaxdigm Co., Ltd.
CEO Sung Jae Kim
TEL 02-6205-2550
EMAIL hydrogold@vaxdigm.com
BUSINESS NUMBER 657-87-02464
ADDRESS 412ho, 201, Songpa-daero, Songpa-gu, Seoul, Republic of Korea
PRIVACY POLICYㅣTERMS AND CONDITIONS
COPYRIGHT © 2026 VAXDIGM. ALL RIGHTS RESERVED.
Vaxdigm Co., Ltd.
CEO Sung Jae Kim
EMAIL hydrogold@vaxdigm.com ㅣ TEL 02-6205-2550
BUSINESS NUMBER 657-87-02464 ㅣ ADDRESS 412ho, 201, Songpa-daero, Sonpa-gu, Seoul, Republic of Korea
PRIVACY POLICYㅣTERMS AND CONDITIONS
COPYRIGHT © 2026 VAXDIGM. ALL RIGHTS RESERVED.
